Publications by authors named "Annenkov Alexey"

We present the first reported case of an isolated small-bowel intestinal juvenile polyp in an adult. This case is particularly noteworthy as it was asymptomatic, detected via computed tomography, localized by capsule endoscopy, and successfully resected via double-balloon endoscopy before the development of acute symptoms.

View Article and Find Full Text PDF

Background And Hypothesis: Activated macrophages, pivotal for driving the immune response in sepsis, express high levels of CD38. Although the circulating levels of its ligand, CD31, increase in sepsis, the functions of CD38 and its ligation remain elusive. This study aimed to elucidate the impact of CD38 ligation on sepsis using single-cell and single-nucleus RNA sequencing (scRNA-seq and snRNA-seq, respectively) to identify a novel therapeutic target for severe sepsis.

View Article and Find Full Text PDF

Case 1: A 75-year-old man underwent distal gastrectomy with Billroth Ⅰ reconstruction and resection of the involved transverse mesocolon. Microscopic examination revealed adenocarcinoma(tub2, tub1), pT4b(SI)N3M0, pStageⅢc. Adjuvant chemotherapy with S-1 was performed for 6 months after the operation.

View Article and Find Full Text PDF

Aims: Although intestinal-type epithelium in Barrett's oesophagus has been traditionally recognized as having a distinct malignant potential, whether this also holds true for cardiac-type epithelium remains controversial. The aim of this study was to identify a type of epithelium that is highly associated with Barrett's tumour.

Methods And Results: We analysed tumours and the corresponding background mucosa with special regard to tumour size in 40 cases of superficial Barrett's tumour by using immunohistochemical staining for CDX2, CD10, MUC2, MUC5AC, and MUC6.

View Article and Find Full Text PDF
Article Synopsis
  • Alpha-methylacyl-coenzyme A racemase is crucial in breaking down branched-chain fatty acids and serves as a marker for various cancers, including prostate and gastrointestinal cancers.
  • In a study of gastric neuroendocrine tumors, none of the grade 1 tumors showed expression of this enzyme, while 67% of grade 2 tumors and 90% of neuroendocrine carcinomas tested positive.
  • The presence of an adenocarcinoma component was common in neuroendocrine carcinomas (72.5%) but absent in lower-grade tumors, indicating different tumorigenic pathways and the enzyme's potential as a distinguishing marker.
View Article and Find Full Text PDF